UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Decreased by Strategy Asset Managers LLC

Strategy Asset Managers LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,171 shares of the healthcare conglomerate's stock after selling 584 shares during the period. Strategy Asset Managers LLC's holdings in UnitedHealth Group were worth $4,639,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of UNH. Allianz SE acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $25,802,000. WealthTrak Capital Management LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $110,000. Biondo Investment Advisors LLC boosted its position in UnitedHealth Group by 2.0% during the fourth quarter. Biondo Investment Advisors LLC now owns 18,381 shares of the healthcare conglomerate's stock worth $9,298,000 after purchasing an additional 358 shares in the last quarter. Allstate Corp lifted its holdings in UnitedHealth Group by 3,187.1% in the 4th quarter. Allstate Corp now owns 27,480 shares of the healthcare conglomerate's stock valued at $13,901,000 after purchasing an additional 26,644 shares in the last quarter. Finally, Maridea Wealth Management LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $704,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.33% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on UNH shares. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. KeyCorp reissued an "overweight" rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Finally, StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Trading Up 1.6 %

Shares of NYSE UNH traded up $8.44 during midday trading on Monday, hitting $524.48. The stock had a trading volume of 5,024,239 shares, compared to its average volume of 4,764,878. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a market capitalization of $479.75 billion, a price-to-earnings ratio of 33.84, a PEG ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a fifty day moving average price of $508.81 and a 200 day moving average price of $543.92.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the business posted $5.83 EPS. The firm's revenue was up 6.8% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.